In the last decade,
researchers have been searching for innovative
platforms, methods, and techniques able to address recurring problems
with the current cancer detection methods. Early disease detection,
fast results, point-of-care sensing, and cost are among the most prevalent
issues that need further exploration in this field. Herein, studies
are focused on overcoming these problems by developing an electrochemical
device able to detect telomerase as a cancer biomarker. Electrochemical
platforms and techniques are more appealing for cancer detection,
offering lower costs than the established cancer detection methods,
high sensitivity inherent to the technique, rapid signal processing,
and their capacity of being miniaturized. Therefore, Au interdigital
electrodes and electrochemical impedance spectroscopy were used to
detect telomerase activity in acute T cell leukemia. Different cancer
cell concentrations were evaluated, and a detection limit of 1.9 ×
105 cells/mL was obtained. X-ray photoelectron spectroscopy
was used to characterize the telomerase substrate (TS) DNA probe self-assembled
monolayer on gold electrode surfaces. Atomic force microscopy displayed
three-dimensional images of the surface to establish a height difference
of 9.0 nm between the bare electrode and TS-modified Au electrodes.
The TS probe is rich in guanines, thus forming secondary structures
known as G-quadruplex that can be triggered with a fluorescence probe.
Confocal microscopy fluorescence images showed the formation of DNA
G-quadruplex because of TS elongation by telomerase on the Au electrode
surface. Moreover, electrodes exposed to telomerase containing 2′,3′-dideoxyguanosine-5′-triphosphate
(ddGTP) did not exhibit high fluorescence, as ddGTP is a telomerase
inhibitor, thus making this device suitable for telomerase inhibitors
capacity studies. The electrochemical method and Au microchip device
may be developed as a biosensor for a point-of-care medical
device.